NASDAQ
1.69USD
-0.05 (-2.87%)
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
12.8M
P/E
—
EPS
—
Beta
1.47
52W range
1.49-19
Day range
1.55–1.76
Open
1.76
Prev close
1.74
Volume
82.1K
Avg volume
118.9K
Dividend
0.00
IPO
2026-08-03
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Cerenome, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for CNSY: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
